Table 4

Kinetic parameters obtained for mutants

KmVmax
nM fmol/min
WT330  (267–393)101  (95–106)
Zn2+ ligands and nearby residues
 D387N1475  (670–2280)24  (18–31)
 P388A>3000 ND
 E424Q650  (489–812)14  (13–16)
 S454A90  (61–119)35  (22–37)
 Y552F527  (196–934)26  (19–33)
Substrate ligands
 R463K328  (188–468)104  (91–117)
 R463I†1580  (1410–1750)90  (83–94)
 K499E193  (117–269)118  (108–129)
 K500R471  (267–675)142  (121–165)
K500E 4-a NDND
 S501A332  (224–440)77  (70–83)
 N519DNDND
 R536K266  (214–318)84  (78–89)
 R536E>3000ND
 T538V1341  (1113–1569)99  (90–108)
 K545R272  (250–294)132  (129–135)
 K545E1166  (917–1415)73  (65–80)
Glycosylation
N459D 387  (189–586)50  (42–58)

The Michaelis-Menten parameters K m andV max for NAAG were determined by saturation kinetics for mutants and compared with native enzyme wild type (WT), see Fig. 3for examples. V max has been adjusted by the relative intensities of protein expression quantitated by an immunoblot by the ratio of WT to mutant. Italics indicate slightly altered migration observed in an immunoblot.

    • 4-a Indicates low level of expression in an immunoblot. ND, indicates not determined. The 95% confidence limits are presented in parentheses.